Al-Shamkhani; Aymen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Al-Shamkhani; Aymen.The latest application filed is for "immunomodulatory antibodies".

Company Profile

4.6.11

Al-Shamkhani; Aymen - Southampton GB
Al-Shamkhani; Aymen - Southhampton GB
AL-SHAMKHANI; Aymen - Otterbourne GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination of a Treg depleting anti-4-1BB antibody and anti-PD1 antibody Grant 11,447,549 - Frendeus , et al. September 20, 2	2022-09-20
Immunomodulatory Antibodies App 20220213207 - Al-Shamkhani; Aymen ; et al.	2022-07-07
Immunomodulatory Antibodies App 20210317222 - Al-Shamkhani; Aymen ; et al.	2021-10-14
Immunomodulatory antibodies Grant 11,001,638 - Al-Shamkhani , et al. May 11, 2	2021-05-11
Novel Antibodies And Combined Use Of A Treg Depleting Antibody And An Immunostimulatory Antibody App 20200207855 - FRENDEUS; Bjorn ; et al.	2020-07-02
Immunomodulatory Antibodies App 20200017594 - Al-Shamkhani; Aymen ; et al.	2020-01-16
Cancer And B-cell Related Disease Therapy App 20190169306 - Glennie; Martin John ; et al.	2019-06-06
Immunomodulatory Antibodies App 20180327504 - Al-Shamkhani; Aymen ; et al.	2018-11-15
Human Immune Therapies Using A Cd27 Agonist In Combination With Another Immune Agonist To Treat Cancer App 20180273631 - GLENNIE; Martin John ; et al.	2018-09-27
Human immune therapies using a CD27 agonist in combination with another immune agonist to treat cancer Grant 9,926,374 - Glennie , et al. March 27, 2	2018-03-27
Human immune therapies using a CD27 agonist alone or in combination with other immune modulators Grant 9,248,183 - Glennie , et al. February 2, 2	2016-02-02
Human Immune Therapies Using A Cd27 Agonist Alone Or In Combination With Other Immune Modulators App 20130336976 - Glennie; Martin John ; et al.	2013-12-19
Human immune therapies using a CD27 agonist alone or in combination with other immune modulators Grant 8,481,029 - Glennie , et al. July 9, 2	2013-07-09
Human immune therapies using a CD27 agonist alone or in combination with other immune modulators App 20110033449 - Glennie; Martin John ; et al.	2011-02-10
Materials and methods relating to the increase in protein activity App 20040047873 - Al- Shamkhani, Aymen ; et al.	2004-03-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.